Page last updated: 2024-10-25

deferoxamine and Alexia Syndrome Without Agraphia

deferoxamine has been researched along with Alexia Syndrome Without Agraphia in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research Excerpts

ExcerptRelevanceReference
"Deferoxamine therapy in lifelong transfusion-dependent anaemias, as beta-thalassemia major, is associated with an increased risk of ototoxic changes."3.74Distortion-product otoacoustic emission: early detection in deferoxamine induced ototoxicity. ( Bertetto, IB; Capobianco, S; Delehaye, E; Meloni, F, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delehaye, E1
Capobianco, S1
Bertetto, IB1
Meloni, F1

Other Studies

1 other study available for deferoxamine and Alexia Syndrome Without Agraphia

ArticleYear
Distortion-product otoacoustic emission: early detection in deferoxamine induced ototoxicity.
    Auris, nasus, larynx, 2008, Volume: 35, Issue:2

    Topics: Adolescent; Adult; Alexia, Pure; beta-Thalassemia; Child; Deferoxamine; Female; Humans; Male; Otoaco

2008